助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   hepatitis-b 的翻译结果: 查询用时:0.082秒
图标索引 在分类学科中查询
所有学科
感染性疾病及传染病
消化系统疾病
中医学
外科学
更多类别查询

图标索引 历史查询
 

hepatitis-b
相关语句
  乙型肝炎
     Objective To probe into the clinical characteristic of the HBeAg-negative chronical hepatitis-B(e-CHB for short)and its relationships with the G1896A mutation in the precore and with the A1762T/G1764A twin-mutation in the basal core promoter(BCP for short).
     目的探讨HBeAg阴性慢性乙型肝炎(以下简称e-CHB)的临床特点及与前C区G1896A变异及基本核心启动子(BCP)区A1762T/G1764A双变异的关系。
短句来源
     Methods The cases were chronic hepatitis-B,with positive HBV-DNA,positive HBeAg and ALT≤1~2 ULN (upper limit of normal).
     方法 病例为慢性乙型肝炎伴有乙型肝炎病毒 (HBV) DNA阳性、乙型肝炎病毒e抗原 (HBeAg)阳性及ALT≤ 1~ 2正常上限值 (ULN)。
短句来源
     Research of the correlation among serum quantity HBV-DNA,clinical diagnosis and pathological degree in children with chronic hepatitis-B
     小儿慢性乙型肝炎血清HBV-DNA定量及临床诊断与病理分度的关系
短句来源
     Analysises of HBV Mark Testing Results in saliva of Patients with Hepatitis-B
     乙型肝炎患者唾液HBV标志物检测结果分析
短句来源
     Results In e-CHB cases,there is older age,and higher proportion in liver cirrhosis and liver cancer than there is in HBeAg-positive chronical hepatitis-B(e+CHB for short)(P<0.05)does.
     结果e-CHB患者其年龄、肝硬化及肝癌发生明显高于HBeAg阳性慢性乙型肝炎(以下简称e+CHB)患者(P<0·05);
短句来源
更多       
  “hepatitis-b”译为未确定词的双语例句
     Application of Microwave-ELISA Two-Step-Test to Hepatitis-B signs check in factory physical examination
     微波-ELISA二步法检测乙肝标志物在工厂体检中的应用
短句来源
     The article had been reported five HBV marks model of 100 Patients with hepatitis -B by ELISA way, the result was made know that total positive rate was 60% > among HBsAg positive rate was 31%, HBeAg positive rate was 12% , HBsAg, HBeAg and Anti -HBc positive rates were 20%.
     用ELISA检测100名乙肝患者唾液中的五种HBV标志物模式,经统计总阳性率为60%,其HBsAg阳性率为31%,HBeAg阳性率为12%; HBsAg、HBeAg抗—HBC三项阳性率为9%;
短句来源
     Objective To study the relation of soluable vascular cell adhesion molecule-1(sVCAM-1)and soluable intercelluar adhesion molecule-1(sICAM-1)with hepatitis-B virus marker(HBVM).
     目的探讨可溶性血管内皮细胞间黏附分子1(sVCAM -1)和可溶性细胞间黏附分子1(sICAM -1)的水平与乙肝病毒标志物之间的关系。
短句来源
     Objective: To investigate the relationship between HBV-DNA determined by the polymerase chain reaction(PCR) assay and Hepatitis-B markers by ELISA method.
     目的:探讨荧光定量PCR检测HBV DNA与HBVm的关系。
短句来源
     Conclusion:Microwave-ELISA Two-Steps-Test is timesaving,simple and high sensitive for testing Hepatitis-B signs,which can reduce the hook phenomenon and can be used to do the large number of HBsAg and HBeAg checks in factory physical examinations. It can hasten the result report and greatly improve the efficiency.
     结论:微波-ELISA二步法检测乙肝标志物具有时间短、操作简便,灵敏度高等特点,用二步法进行检测,可减少HOOK现象,可用于检测HBsAg和HBeAg的大量工厂体检中,能加快出报告时间,大大提高工作效率。
短句来源
更多       
  相似匹配句对
     Hepatitis B vaccination.
     乙型肝炎疫苗免疫
短句来源
     Hepatitis C and Detection for it
     丙型肝炎及其检测
短句来源
     Die Hepatitis G
     庚型肝炎
短句来源
     Hepatitis B Virus
     乙型肝炎病毒
短句来源
     HEPATITIS B VIRUS-INDUCED GLCMERUICNEFPHRITIS
     乙肝病毒感染后肾小球肾炎
短句来源
查询“hepatitis-b”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  hepatitis-b
We investigated whether human recombinant IFN-α modulates serum concentrations of hyaluronic acid (HA) and type III procollagen aminoterminal propeptide (P-III-NP) in 56 patients with chronic hepatitis-B under IFN-α therapy.
      
Public Health Dilemmas Concerning a 2-year old Hepatitis-B Carrier - Response
      
Response to: "Public Health Dilemmas Concerning a Two-year old Hepatitis-B Carrier"
      
Response to: "Public Health Dilemmas Concerning a 2-year-old Hepatitis-B Carrier"
      
Response to: "Public Health Dilemmas Concerning a Two-year-old Hepatitis-B Carrier"
      
更多          


Transfer factor (TP) is a dialysable (ultrafilterable) extract of sensitised leukocytes. It transfers cellular immunity from a skin test positive donor to a skin test negative recipient. Currently TF is recognized as one of the most potent immunological reagents. In this paper the detailed method for preparation of transfer factor from normal blood bank donors has been described and some physico-chemical and biological properties of the TF preparations have been examined. The production of TF is briefly as follows:...

Transfer factor (TP) is a dialysable (ultrafilterable) extract of sensitised leukocytes. It transfers cellular immunity from a skin test positive donor to a skin test negative recipient. Currently TF is recognized as one of the most potent immunological reagents. In this paper the detailed method for preparation of transfer factor from normal blood bank donors has been described and some physico-chemical and biological properties of the TF preparations have been examined. The production of TF is briefly as follows: After separation of the plasma (for plasma products), the buffy coats are harvested and pooled. The contaiminating red blood cells are disrupted by tris buffered or isotonic NH_4Cl solution. The pooled leukocytes having been washed iwice with cold normal saline are then alternately frozen and thawed ten times with dry ice in acetone and a 37℃ water bath. The cell lysate is placed in dialysis tubing and dialysed in the cold for 36~48 hours against running pyrogenfree deionized water. The dialysate is lyophilized. The yellowish white powder is saved and redissolved in the desired volume of pyrogen-free deionized water, and passed through a Seitz filter (EKS). 2ml of the sterile TF solution (equivalent to the dialysate of 4×10~8 leukocytes) are placed in each ampoule. The final product is stored at -20℃.The TF preparation is protein-free as determined by protein precipitating reagents. It contains ca. 148μg of peptides and 14μg of ribose per mg of dry powder. The ultraviolet absorption curve gives a peak at 250~251nm. Adenine, guanine and uracil are present in the paper chromatogram of the TF acid hydrolysate. Silica- gel thin layer chromatography reveals four spots stained with ninhydrin. Sephadex G-25 filtration gives reproducibly a characteristic elution pattern yielding 3 main peaks and several small peaks with many of the eluted peaks beyond the total volume of the column. The results of animal experiments show that the TF preparations are non-toxic, non-anaphylactic and non-antigenic.So far over 160 patients (variously afflicted with herpes zoster, chronic hepatitis B, systemic lupus erythematosus, primary carcinoma of the liver, carcinoma of the lung and leukemia) have been treated with the TF preparations. The results will be published elsewhere.

转移因子是致敏白细胞中的可透析物质,能将一个有免疫能力的人的某些细胞免疫力转移给无免疫力的人。所以供给转移因子可能是一种有效的免疫治疗措施。本文详细介绍综合利用血源制备正常人转移因子的方法,并分析其某些理化性质和生物学性质。收集分离血浆后的白细胞层,用三羟甲基氨基甲烷缓冲的或等渗的氯化铵溶液破坏其中污染的红细胞,白细胞经生理盐水洗涤后进行10次冻融,白细胞匀浆对流动去离子水透析,透析液冷冻干燥、除菌分装。每安瓿2毫升转移因子注射液相当4×10~8个白细胞的透析物,保存于-20℃备用。本制剂蛋白质定性检查阴性;每毫克干粉约含多肽148微克、核糖14微克;在250~251毫微米有吸收高峰;转移因子酸水解液硷基纸层析有三种硷基;硅胶薄板层析呈四个茚三酮显色点;葡聚糖G-25凝胶过滤呈可重复的特征性洗脱图谱,具有3个主要峰及若干个小峰,主要洗脱部分在V_t之后。动物实验表明此制剂无毒性、无过敏性和抗原性。本制剂已用于临床治疗带状疱疹、系统性红斑狼疮、慢性乙型肝炎、原发性肝癌、肺癌及白血病等一百六十余例,结果将另文发表。

The cellular immunity of different types of hepatitis cases was studied by an improved leucocyte migration inhibition test. Using phytohaemagglutinin (PHA) as mitogen stimulator, 53.4% of 133 chronic persistent hepatitis cases. 72.2% of 18 chronic active hepatitis cases, 50% of 12 acute hepatitis cases and all of the 27 healthy controls showed inhibition of leucocyte migration. Using the crude hepatitis B surface antigen (HBsAg) as antigen. 77.2% of 79 hepatitis cases showed inhibition. When liver specific lipoprotein(LPI)was...

The cellular immunity of different types of hepatitis cases was studied by an improved leucocyte migration inhibition test. Using phytohaemagglutinin (PHA) as mitogen stimulator, 53.4% of 133 chronic persistent hepatitis cases. 72.2% of 18 chronic active hepatitis cases, 50% of 12 acute hepatitis cases and all of the 27 healthy controls showed inhibition of leucocyte migration. Using the crude hepatitis B surface antigen (HBsAg) as antigen. 77.2% of 79 hepatitis cases showed inhibition. When liver specific lipoprotein(LPI)was used as antigen. 18.1% of the133 chronic persistent hepatitis cases, 44.4% of 18 chronic active hepatitis cases, 25.0% of 12 active hepatitis cases and 1 in 32 healthy controls showed abnormal responses, in cellular immunity.

应用改进的白细胞移动抑制试验测试不同类型肝炎患者的细胞免疫状态。以植物血凝素(PHA)为刺激因子,133名迁肝患者中有53.4%,18例慢活肝患者中有72.2%,12例急性肝炎患者中有50%呈现白细胞移动抑制,而27名健康人均出现抑制现象。以粗制乙型肝炎表面抗原(HBsAg)为抗原,在79例肝炎患者中,有77.2%出现异常反应,而在25名健康人中只有4%为阳性。以肝细胞膜脂蛋白(LPI)为抗原,133例迁肝中有18.1%,18例慢活肝中有44.4%,12例急性肝炎中有25.0%呈异常反应,而在32名健康人中只有3.1%异常。

The purification of the 22nm form of hepatitis B surface antigen (HBsAg) was carried out by immune affinity chromatography and isopycnic banding in sucrose. The purified preparations of HBsAg were solubilized with sodium dodecyl sulfate and urea under reducing conditions and subsequently fractionated by sodium dodecyl sulfate-urea polyacrylamide gel electrophoresis. Eight polypeptides were isolated from HBsAg and designated as p-1 through p-8 in the order of their decreasing mobilities and have molecular weights...

The purification of the 22nm form of hepatitis B surface antigen (HBsAg) was carried out by immune affinity chromatography and isopycnic banding in sucrose. The purified preparations of HBsAg were solubilized with sodium dodecyl sulfate and urea under reducing conditions and subsequently fractionated by sodium dodecyl sulfate-urea polyacrylamide gel electrophoresis. Eight polypeptides were isolated from HBsAg and designated as p-1 through p-8 in the order of their decreasing mobilities and have molecular weights of 22,500, 26,000, 48,000, 52,000, 59,000, 76,000, 82,000 and 290,000 respectively. The p-1, p-2 and p-6 components are the major forms. Individual polypeptides isolated from HBsAg possess the antigenicity of HBsAg as determined by reverse passive hemagglutination assay. Seven polypeptides were used to hyperimmunize guinea pigs by Freund's complete adjuvant. All animals produced specific antibodies against native HBsAg by passive hemagglutination and double diffusion assays and these antibodies showed no reaction to normal human serum components by countercurrent-immuno-electrophorcsis. Thus, it is possible that the polypeptides of HBsAg may serve as vaccine against hepatitis B in prevention of HBV infection.

本文报告HBsAg多肽的分离,各个多肽的分子量和它们的抗原性,并对一些主要多肽作为乙型肝炎疫苗的可能性进行讨论,认为HBsAg的多肽有可能作为乙型肝炎疫苗预防乙型肝炎病毒的感染。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关hepatitis-b的内容
在知识搜索中查有关hepatitis-b的内容
在数字搜索中查有关hepatitis-b的内容
在概念知识元中查有关hepatitis-b的内容
在学术趋势中查有关hepatitis-b的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社